Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing for 482929106 since 12/18/2024, newest first.
| Filer | % of Class | Filed | |
|---|---|---|---|
|
Samsara BioCapital, L.P.
13D/A
Amendment 3
|
54.2% |
5/22/2026
Event 5/20/2026
|
|
| Samsara BioCapital, L.P. | 44.8% | ||
| Samsara BioCapital GP, LLC | 44.9% | ||
| Samsara Opportunity Fund, L.P. | 9.3% | ||
| Samsara Opportunity Fund GP, LLC | 9.3% | ||
| Srinivas Akkaraju | 54.2% | ||
|
Samsara BioCapital, L.P.
13D/A
Amendment 2
|
56.5% |
2/17/2026
Event 12/18/2025
|
|
| Samsara BioCapital, L.P. | 47.9% | ||
| Samsara BioCapital GP, LLC | 47.9% | ||
| Samsara Opportunity Fund, L.P. | 8.6% | ||
| Samsara Opportunity Fund GP, LLC | 8.6% | ||
| Srinivas Akkaraju | 56.5% | ||
|
RTW Investments, LP
13G
|
5.7% |
2/17/2026
Event 12/31/2025
|
|
| RTW Investments, LP | 5.7% | ||
| Roderick Wong | 5.7% | ||
|
Samsara BioCapital, L.P.
13D/A
Amendment 1
|
56.5% |
12/22/2025
Event 12/22/2025
|
|
| Samsara BioCapital, L.P. | 50.0% | ||
| Samsara BioCapital GP, LLC | 50.0% | ||
| Samsara Opportunity Fund, L.P. | 6.5% | ||
| Samsara Opportunity Fund GP, LLC | 6.5% | ||
| Srinivas Akkaraju | 56.5% | ||
|
Invus Global Management, LLC
13G/A
Amendment 3
|
1.5% |
7/29/2025
Event 6/30/2025
|
|
| Invus Public Equities, L.P. | 1.5% | ||
| Invus Public Equities Advisors, LLC | 1.5% | ||
| Invus Global Management, LLC | 1.5% | ||
| Siren, L.L.C. | 1.5% | ||
| Raymond Debbane | 1.5% | ||
|
EcoR1 Capital, LLC
13G/A
Amendment 2
|
1.1% |
5/15/2025
Event 3/31/2025
|
|
| EcoR1 Capital, LLC | 1.1% | ||
| Oleg Nodelman | 1.1% | ||
| EcoR1 Capital Fund Qualified, L.P. | 1.0% | ||
|
Samsara BioCapital, L.P.
13D
|
61.2% |
3/25/2025
Event 3/18/2025
|
|
| Samsara BioCapital, L.P. | 61.2% | ||
| Samsara BioCapital GP, LLC | 61.2% | ||
| Srinivas Akkaraju | 61.2% | ||
| Gilead Sciences, Inc. 13G/A Amendment 2 | 3.9% |
3/20/2025
Event 3/18/2025
|